06 Oct 2020 --- Cellibre Inc. has closed an “oversubscribed” round of bridge financing to bring its fermented cannabinoids closer to commercialization. Founded in 2017, the California-based start-up is using its technology to improve the sourcing, production and consumption of cannabinoids.
